• The agency also extended the deadline for drugmakers to enter participation agreements to July 17, from June 30. • CMS ...
Under the Bridge program, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 copay. Extending the short-term GLP-1 Bridge program is good news for eligible Medicare ...
MedPage Today on MSN
FDA Staff Raises Concerns on Two Cancer Drug Applications
The Oncologic Drugs Advisory Committee will meet for the first time in 9 months ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...
Please provide your email address to receive an email when new articles are posted on . Aquestive Therapeutics’ Anaphylm sublingual film is about the size of a postage stamp. Anaphylm’s time to ...
According to the US FDA (https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products). "NV-387 ...
FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information FDA ...
The U.S. Centers for Medicare & Medicaid Services has extended application and participation deadlines for drugmakers and states to join its new Medicaid drug pricing model. The program, announced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results